Skip to main content
. 2022 Apr 14;13:881321. doi: 10.3389/fimmu.2022.881321

Figure 1.

Figure 1

clinical features between the two groups. Compared the difference of the levels of ALT, HBV DNA, HBsAg and HBeAg at each follow-up point between the group 1 (n=15) and group 2 (n=10). *p < 0.05, ****p < 0.0001.